Author

E.V. Shvedova

Observed name: E. V. Shvedova

Institution: Microgen (United States)

Observed institutions: Microgen (United States), Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP), Federal Medical-Biological Agency

ORCID: 0000-0002-9229-3677

Observed ORCID: 0000-0002-9229-3677

OpenAlex ID: A5054296931

Methods for evaluating the specifi c activity of preparations of human antirhesus Rho(D): current status of the problem

2020 · E.V. Shvedova, E.Yu. Kudasheva, et al. · Immunologiya · 6

Development of a Pharmacopoeia Standard for the quantitative determination of the activity of human immunoglobulin antirhesus Rho(D)

2023 · E.V. Shvedova, A.G. Klepikova, et al. · Immunologiya · 4

Development of criteria for immobilization of human erythrocytes of phenotypes R1R1 and R2R2 on the solid phase in determining the content of anti-D-antibodies IgG in immunoglobulin human antirhesus Rho(D) preparations by enzyme immunoassay

2022 · E.V. Shvedova, S.A. Leshina, et al. · Immunologiya · 2

Development of acceptance criteria for the results of anti-D IgG quantification in human anti-D (Rhо) immunoglobulin preparations by enzyme immunoassay

2022 · E. V. Shvedova, S. A. Leshina, et al. · Biological Products Prevention Diagnosis Treatment · 1

Genetic characterization of production strains of measles, rubella, and mumps viruses by high-throughput sequencing

2026 · A. I. Zheltukhina, A. B. Komissarov, et al. · Biological Products Prevention Diagnosis Treatment

Works count: 5

Citation count: 13

H-index: 2

I10-index: